Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekFierceBiotech ↗
GSK's risvutatug rezetecan has achieved a median overall survival of 18.5 months in a phase 3 trial, painting …
The WeekBriefing
Karyopharm secured an extra month to negotiate with creditors or seek a deal. The same weekly tape also pointe…
The WeekFiercePharma ↗
Following formal sign-off from the FDA, Handa Pharmaceuticals' branded drug reformulation strategy has paid of…
The WeekFierceBiotech ↗
The FDA has delayed its approval decision for Exelixis' oral kinase inhibitor in combination with Roche's Tece…
The WeekBriefing
Members of the American Diabetes Association are escalating a June conference dispute into a broader boycott. …
The WeekSTAT News ↗
A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could…
The WeekSTAT News ↗
An E.U. AG recommended annulling part of a directive that requires drugmakers to finance 80% of the costs of w…
The WeekBioPharma Dive ↗
RA Capital has already participated in four biotech financings in September. Meanwhile, Janus Henderson has be…
The WeekPharmaceutical Technology ↗
Though yet to be finalised, the initial recommendation would mean the injectable PrEP would not be covered on …
The WeekPharmaceutical Technology ↗
At ERS 2026, investigators reported their findings from their review of the Oxford Asthma Attack Risk Scale Me…
The WeekBioPharma Dive ↗
Manufacturing hurdles are just one challenge the industry must overcome to commercialize personalized mRNA can…
The WeekPharmaceutical Technology ↗
Biotechs and investors are increasingly altering their strategies amid changes in the development and commerci…
The WeekFiercePharma ↗
In his first interview after taking the reins of the FDA's Oncology Center of Excellence, Angelo de Claro, M.D…
The WeekFierceBiotech ↗
In his first interview after taking the reins of the FDA's Oncology Center of Excellence, Angelo de Claro, M.D…
The WeekBriefing
A newly approved AI tool is designed to scan EKGs for severe heart attacks and, the company says, rarer patter…
The WeekPharmaceutical Technology ↗
ABEC is to open a new manufacturing facility in Wilson, North Carolina, US, expanding its network for biopharm…
The WeekSTAT News ↗
The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines. They could al…
The WeekPharmaVoice ↗
Oncology still accounts for nearly two out of five pipeline drugs, while obesity entered the top 10 indication…
The WeekBioPharma Dive ↗
Announced mere weeks after Biohaven sold off rights to the therapy, opakalim, the halt affects a study some an…
The WeekPharmaVoice ↗
Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and…
The WeekBioPharma Dive ↗
Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and…
The WeekPharmaVoice ↗
Manufacturing hurdles are just one challenge the industry must overcome to commercialize personalized mRNA can…
The WeekFiercePharma ↗
Bayer has won first-line approval for its tyrosine kinase inhibitor, Hyrnuo, in patients with HER2-mutant non-…
The WeekFierceBiotech ↗
Clinical research company nPhase has launched an end-to-end clinical data management platform designed to help…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.